Inotiv (NOTV)
Healthcare · Medical - Diagnostics & Research
1 member of Congress has disclosed 1 trade in Inotiv (NOTV) since 2022: 0 buys and 1 sale. The most recent was disclosed on Jan 20, 2023.
- Trades disclosed
- 1
- Members trading
- 1
- Buys / sells
- 0 / 1
- Reported value
- $1K–$15K
Keep following the company.
Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.
What else is happening at NOTV
All research →Company filings and public records connected to this stock, ordered by when they became public or were first observed.
NOTV: third_quarter 2026 lobbying report
Animal research models to biopharmaceuticals, academic and government research for realizing life-saving medications. Anima research models to biopharmaceuticals, academic and government research for realizing life saving medication.
Public: Oct 15, 2026, 10:48 AM EDTOriginal source ↗NOTV: second_quarter 2026 lobbying report
Anima research models to biopharmaceuticals, academic and government research for realizing life saving medication. Animal research models to biopharmaceuticals, academic and government research for realizing life-saving medications.
Public: Jul 20, 2026, 2:18 PM EDTOriginal source ↗
Who traded NOTV
- Rep. Chris Jacobs (R-NY-27)0 buys · 1 sale01Jan 20, 2023
All trades
- Jan 20, 2023$1K–$15K
From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.